Novo CEO pressed by Senate to chop rates of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the business would consider new talks with insurers in regards to the record rates of Wegovy and copyright should they pledge to keep the medicines on their formularies. Don't pass up https://kethek.com/